- Home
- NWTG vs APRE Comparison
NWTG vs APRE Comparison
Compare NWTG & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTG
- APRE
- Stock Information
- Founded
- NWTG 2018
- APRE 2006
- Country
- NWTG United States
- APRE United States
- Employees
- NWTG N/A
- APRE N/A
- Industry
- NWTG Recreational Games/Products/Toys
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NWTG Consumer Discretionary
- APRE Health Care
- Exchange
- NWTG Nasdaq
- APRE Nasdaq
- Market Cap
- NWTG 8.5M
- APRE 9.4M
- IPO Year
- NWTG N/A
- APRE 2019
- Fundamental
- Price
- NWTG $1.86
- APRE $1.54
- Analyst Decision
- NWTG
- APRE Strong Buy
- Analyst Count
- NWTG 0
- APRE 1
- Target Price
- NWTG N/A
- APRE $20.00
- AVG Volume (30 Days)
- NWTG 142.3K
- APRE 34.4K
- Earning Date
- NWTG 11-13-2025
- APRE 11-06-2025
- Dividend Yield
- NWTG N/A
- APRE N/A
- EPS Growth
- NWTG N/A
- APRE N/A
- EPS
- NWTG N/A
- APRE N/A
- Revenue
- NWTG $5,560,000.00
- APRE $841,012.00
- Revenue This Year
- NWTG $98.37
- APRE N/A
- Revenue Next Year
- NWTG $49.25
- APRE N/A
- P/E Ratio
- NWTG N/A
- APRE N/A
- Revenue Growth
- NWTG 304.36
- APRE N/A
- 52 Week Low
- NWTG $1.35
- APRE $1.41
- 52 Week High
- NWTG $119.10
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- NWTG 53.06
- APRE 43.27
- Support Level
- NWTG $1.78
- APRE $1.49
- Resistance Level
- NWTG $2.05
- APRE $1.66
- Average True Range (ATR)
- NWTG 0.14
- APRE 0.08
- MACD
- NWTG 0.00
- APRE 0.00
- Stochastic Oscillator
- NWTG 44.32
- APRE 27.00
About NWTG Newton Golf Company Inc. Common Stock
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.